β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage

被引：0
|
作者：
Erik Portelius
Robert A Dean
Ulf Andreasson
Niklas Mattsson
Anni Westerlund
Maria Olsson
Ronald Bradley Demattos
Margaret M Racke
Henrik Zetterberg
Patrick C May
Kaj Blennow
机构：
[1] University of Gothenburg,Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy
[2] Eli Lilly and Company,Lilly Research Laboratories
[3] University of California San Francisco,San Francisco VA Medical Center, Center for Imaging of Neurodegenerative Diseases (CIND)
[4] UCL Institute of Neurology,undefined
来源：
Alzheimer's Research & Therapy | / 6卷
关键词：
Amyloid Precursor Protein; Amyloid Precursor Protein Processing; BACE1 Inhibitor; Pharmacodynamic Marker; BACE1 Activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Identification of BACE (β-site amyloid precursor protein cleaving enzyme) expression and activity in pancreatic cells
    Casas, S.
    Piquer, S.
    Julia, M.
    Altirriba, J.
    Gomis, R.
    Novials, A.
    [J]. DIABETOLOGIA, 2006, 49 : 317 - 317
  • [42] Control of β-Site Amyloid Precursor Protein-Cleaving Enzyme-1 Expression by Protein Kinase C-λ/ι and Nuclear Factor κ-B
    Sajan, Mini P.
    Leitges, Michael
    Park, Colin
    Diamond, David M.
    Wu, Jin
    Hansen, Barbara C.
    Duncan, Mildred A.
    Apostolatos, Christopher A.
    Apostolatos, Andre H.
    Kindy, Mark
    Farese, Robert, V
    [J]. CURRENT ALZHEIMER RESEARCH, 2021, 18 (12) : 941 - 955
  • [43] Critical analysis of the use of beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in the treatment of Alzheimer's disease
    Evin, Genevieve
    Barakat, Adel
    [J]. DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2014, 4 : 1 - 19
  • [44] Antibacterial and β-amyloid precursor protein-cleaving enzyme 1 inhibitory polyketides from the fungus Aspergillus chevalieri
    Wang, Qing-Yuan
    Chen, He-Ping
    Wu, Kai-Yue
    Li, Xinyang
    Liu, Ji-Kai
    [J]. FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [45] Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation
    O'Neill, Brian T.
    Beck, Elizabeth M.
    Butler, Christopher R.
    Nolan, Charles E.
    Gonzales, Cathleen
    Zhang, Lei
    Doran, Shawn D.
    Lapham, Kimberly
    Buzon, Leanne M.
    Dutra, Jason K.
    Barreiro, Gabriela
    Hou, Xinjun
    Martinez-Alsina, Luis A.
    Rogers, Bruce N.
    Villalobos, Anabella
    Murray, John C.
    Ogilvie, Kevin
    LaChapelle, Erik A.
    Chang, Cheng
    Lanyon, Lorraine F.
    Steppan, Claire M.
    Robshaw, Ashley
    Hales, Katherine
    Boucher, Germaine G.
    Pandher, Karamjeet
    Houle, Christopher
    Ambroise, Claude W.
    Karanian, David
    Riddell, David
    Bales, Kelly R.
    Brodney, Michael A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (10) : 4476 - 4504
  • [46] First Demonstration of Cerebrospinal Fluid and Plasma Aβ Lowering with Oral Administration of a β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman Primates
    Sankaranarayanan, Sethu
    Holahan, Marie A.
    Colussi, Dennis
    Crouthamel, Ming-Chih
    Devanarayan, Viswanath
    Ellis, Joan
    Espeseth, Amy
    Gates, Adam T.
    Graham, Samuel L.
    Gregro, Allison R.
    Hazuda, Daria
    Hochman, Jerome H.
    Holloway, Katharine
    Jin, Lixia
    Kahana, Jason
    Lai, Ming-tain
    Lineberger, Janet
    McGaughey, Georgia
    Moore, Keith P.
    Nantermet, Philippe
    Pietrak, Beth
    Price, Eric A.
    Rajapakse, Hemaka
    Stauffer, Shaun
    Steinbeiser, Melissa A.
    Seabrook, Guy
    Selnick, Harold G.
    Shi, Xiao-Ping
    Stanton, Matthew G.
    Swestock, John
    Tugusheva, Katherine
    Tyler, Keala X.
    Vacca, Joseph P.
    Wong, Jacky
    Wu, Guoxin
    Xu, Min
    Cook, Jacquelynn J.
    Simon, Adam J.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (01): : 131 - 140
  • [47] β-Site amyloid precursor protein-cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin-related receptor with A-type repeats, soluble amyloid precursor protein, and tau
    Tsolakidou, Amalia
    Alexopoulos, Panagiotis
    Guo, Liang-Hao
    Grimmer, Timo
    Westerteicher, Christine
    Kratzer, Martina
    Jiang, Meizi
    Bujo, Hideaki
    Roselli, Francesco
    Leante, Maria Rosaria
    Livrea, Paolo
    Kurz, Alexander
    Perneczky, Robert
    [J]. ALZHEIMERS & DEMENTIA, 2013, 9 (04) : 386 - 391
  • [48] The enhancement of amyloid precursor protein and β-site amyloid cleavage enzyme 1 interaction: Amyloid-β production with aging
    Zou, Lin
    Yang, Rongxi
    Zhang, Penghui
    Da, Yi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 25 (03) : 401 - 407
  • [49] Discovery of Extremely Selective Fused Pyridine-Derived β-Site Amyloid Precursor Protein-Cleaving Enzyme (BACE1) Inhibitors with High In Vivo Efficacy through 10s Loop Interactions
    Ueno, Tatsuhiko
    Matsuoka, Eriko
    Asada, Naoya
    Yamamoto, Shiho
    Kanegawa, Naoki
    Ito, Mana
    Ito, Hisanori
    Moechars, Diederik
    Rombouts, Frederik J. R.
    Gijsen, Harrie J. M.
    Kusakabe, Ken-ichi
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (19) : 14165 - 14174
  • [50] Alzheimer's β-secretase, β-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase
    Kitazume, S
    Tachida, Y
    Oka, R
    Shirotani, K
    Saido, TC
    Hashimoto, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 13554 - 13559
12345